SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-020964
Filing Date
2018-04-17
Accepted
2018-04-17 17:01:15
Documents
4
Period of Report
2018-06-11
Effectiveness Date
2018-04-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv491126_def14a.htm DEF 14A 413029
2 GRAPHIC casi_logo.jpg GRAPHIC 17287
3 GRAPHIC proxycard_001.jpg GRAPHIC 117344
4 GRAPHIC proxycard_002.jpg GRAPHIC 48677
  Complete submission text file 0001144204-18-020964.txt   667041
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-20713 | Film No.: 18759566
SIC: 2836 Biological Products, (No Diagnostic Substances)